Colostrinin™: A naturally occurring compound derived from mammalian colostrum with efficacy in treatment of neurodegenerative diseases, including Alzheimer's

Expert Opinion on Pharmacotherapy

Volumn 9, Issue 14, 2008, Pages 2553-2559

  Stewart, Michael G ^a  

^a OPEN UNIVERSITY   (United Kingdom)

Author keywords

amyloid; Colostrinin ; Neurodegenerative disease; Neuroprotection; Nutraceutical; Reduced oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; ANTIDEPRESSANT AGENT; COGNISURE; COLOSTRININ; NUTRACEUTICAL; PLACEBO; PSYCHOTROPIC AGENT; SELENIUM; UNCLASSIFIED DRUG; COLOSTRININE; PEPTIDE;

ABSENCE OF SIDE EFFECTS; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DEPRESSION; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; DRUG APPROVAL; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; ELDERLY CARE; HUMAN; IMMUNOMODULATION; LD 50; LOW DRUG DOSE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PASSIVE IMMUNIZATION; PATENT; PROTEIN AGGREGATION; RISK REDUCTION; ANIMAL; CHEMISTRY; COLOSTRUM; FEMALE; ISOLATION AND PURIFICATION; MALE; MAMMAL;

ALZHEIMER DISEASE; ANIMALS; CLINICAL TRIALS AS TOPIC; COLOSTRUM; FEMALE; HUMANS; MALE; MAMMALS; NEURODEGENERATIVE DISEASES; PEPTIDES;

EID: 54349088496     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.9.14.2553     Document Type: Article

References (34)

1. Hall SH. The quest for a smart pill. Sci Am 2003;289(3):54-65
2. Boldogh I, Kruzel ML. Colostrinin™ an oxidative stress modulator for prevention and treatment of age-related disorders. J Alzheimers Dis 2008;13(3):303-21
3. Rattray M. Technology evaluation: colostrinin, ReGen. Curr Opin Mol Ther 2005;7(1)78-84
4. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders (IV-TR). 4th edition-text revised. APA, Washington, DC; 2000
5. McKhann G, Drachman DA, Folstein M, et al. Clinical diagnosis of Alzheimer's disease-report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44
6. Dubois B, Feldman HF, Claudia Jacava C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-46
7. Smith AD, Jobst KA. Use of structural imaging to study the progression of Alzheimer's disease. Br Med Bull 1996;52(3):575-86
8. Rogers SL, Doody RS, Pratt RD, Leni JR. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study. Eur Neuropsychopharmacol 2000;10(3):195-203
9. Burns A, Gauthier S, Perdomo C. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2007;22(8):806-12
10. Shah RS, Lee HG, Siongwei Z, et al. Current approaches in the treatment of Alzheimer's disease. Biomed Pharmacother 2008;62(4):199-207
11. Luchsinger JA, Tang MX, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003;60(2):203-8
12. Janusz M, Lisowski J, Franek F. Isolation and characterization of a proline-rich polypeptide from ovine colostrums. FEBS Lett 1974;49:276-9
13. Kruzel M, Janusz M, Lisowski J, et al. Towards an understanding of biological role of colostrinin peptides. J Mol Neurosci 2001;17:115-25
14. Kruzel ML, Polanowski A, Wilusz T, et al. The alcohol induced conformational changes in casein micelles: a new challenge for the purification of colostrinin. Protein J 2004;23:127-33
15. Inglot AD, Janusz M, Lisowski J. Colostrinin: a proline-rich polypeptide from ovine colostrum is a modest cytokine inducer in human leukocytes. Arch Immunol Ther Exp 1996;44(4):215-24
16. Janusz M, Lisowski J. Proline-rich polypeptide (PRP) an immunomodulatory peptide from ovine colostrums. Arch Immunol Ther Exp 1993;41:275-9
17. Bacsi A, Aguilera-Aguirre L, German P, et al. Colostrinin decreases spontaneous and induced mutation frequencies at the hprt locus in Chinese hamster V79 cells. J Exp Ther Oncol 2006;5:249-59
18. Boldogh I, Aguilera-Aguirre L, Bacsi A, et al. Colostrinin decreases hypersensitivity and allergic responses to common allergens. Int Arch Allergy Immunol 2008;146(4):298-306
19. Bacsi A, Stanton GJ, Hughes TK, et al. Colostrinin-driven neurite outgrowth requires p53 activation in PC12 cells. Cell Mol Neurobiol 2005;25:1123-39
20. Bacsi A, Woodberry M, Kruzel ML, Boldogh I. Colostrinin delays the onset of proliferative senescence of diploid murine fibroblast cells. Neuropeptides 2007;41:93-101
21. Schuster D, Rajendran A, Hui SW, et al. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid. Neuropeptides 2005;39(4)19-426
22. Boldogh ITK, Hughes TK, Georgiades JA, Stanton J. Antioxidant and cell-differentiating activity of colostrinin and its component peptides (CCP) in cell culture. Psychogeriatr Ann 2001;4:57-65
23. Boldogh I, Liebenthal D, Hughes TK, et al. Modulation of 4HNE-mediated signaling by proline-rich peptides from ovine colostrums. J Mol Neurosci 2003;20:125-34
24. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128
25. Dr Zwart LL, Meerman H, Commandeur JN, Vermeulen NP. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 1999;26:202-26
26. Stewart MG, Banks D. Enhancement of long-term memory retention by Colostrinin in one-day-old chicks trained on a weak passive avoidance learning paradigm. Neurobiol Learn Mem 2006;86:66-71
27. Popik P, Bobula PB, Janusz M, et al. Colostrinin, a polypeptide isolated from early milk, facilitates learning and memory in rats. Pharmacol Biochem Behav 1999;64:183-9
28. Boldogh I, Bacsi L, Agulera-Aguirre L, et al. Colostrinin™ increases the lifespan and neurological performance of mice. Neurodegener Dis 2007;4(Suppl. 1):264
29. Boldogh I, Bacsi A, Agulera-Aguirre L, et al. Colostrinin™ increases the lifespan and neurological performance of mice. Proceedings from 8th International Conference on AP/AD; Salzburg, Austria; 2007. p. 283-7
30. Popik P, Galoch Z, Janusz M, et al. Cognitive effects of Colostral-Val nonapeptide in aged rats. Behav Brain Res 2001;118:201-8
31. Leszek J, Inglot AD, Janusz M, et al. Colostrinin: a proline-rich polypeptide (PRP), complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Arch Immunol Ther Exp Warsz 1999;47:377-85
32. Leszek J, Inglot AD, Janusz M, et al. Colostrinin praline rich polypeptide complex from ovine colostrum-a long-term study of its efficacy in Alzheimer's disease. Med Sci Monit 2002;8:PI93-6
33. Bilikiewicz A, Gaus W. Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease. J Alzheimers Dis 2004;6:17-26
34. Zablcocka A, Janusz M, MacAlca J, Lisowski J. A proline-rich polypeptide complex and its nonapeptide fragment inhibit nitric oxide production induced in mice. Regul Pept 2005;125:35-9